Study of the BDNF-Val66Met Polymorphism in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal

Centre Hospitalier Esquirol

Status: Completed

Conditions: Alcohol Dependence

Study type: Observational

Funder types: Other

Identifiers

NCT02146963

2014-A00613-44

Details and patient eligibility

About

This study is complementary to the main study "Brain Derived Neurotrophic Factor Serum Levels Evolution During the Six Months After Alcohol Withdrawal " NCT01491347.

The purpose of this study is to evaluate the Bdnf gene - Val66Met polymorphism in subjects with alcohol dependence according to their alcohol consumption status 6 months after withdrawal (relapse or abstinence), in relation to the presence of psychiatric co-morbidities.

Enrollment: 180 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• participation to the study "BDNF serum levels evolution during 6 months after alcohol withdrawal" (main study)
• criteria from the main study

Exclusion criteria

• criteria from the main study
• released or out from the main study before the follow-up at 4 months after withdrawal

Trial design

180 participants in 1 patient group

alcohol withdrawal